OP
CRBP icon

ORG Partners’s Corbus Pharmaceuticals CRBP Stock Holding History

ORG Partners’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$814 Hold
100
– – ﹤0.01% 1562
2025
Q3 		$1.26K Hold
100
– – ﹤0.01% 1371
2025
Q2 		$716 Hold
100
– – ﹤0.01% 1369
2025
Q1 		$503 Buy
+100
New +$883 ﹤0.01% 1273

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ORG Partners's CRBP Position: Q4 2025 in Review

ORG Partners held its Corbus Pharmaceuticals (CRBP) position steady in Q4 2025 at 100 shares worth $814. The position accounts for ﹤0.01% of the portfolio, ranked #1562.

ORG Partners first reported a position in CRBP in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.26K in Q3 2025. 100 funds tracked by Wall St. Rank hold CRBP as of Q4 2025.

  • ORG Partners held 100 shares of Corbus Pharmaceuticals worth $814 as of Q4 2025.
  • ORG Partners left its Corbus Pharmaceuticals share count unchanged in Q4 2025.
  • Corbus Pharmaceuticals made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #1562 holding.
  • ORG Partners first reported a position in Corbus Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • ORG Partners's Corbus Pharmaceuticals position peaked at $1.26K in Q3 2025.
  • 100 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.